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In guided bone tissue engineering, successful ingrowth of MSCs depends primarily
on the nature of the scaffold. It is well-known that only seconds after implantation,
biomaterials are coated by a layer of adsorbed proteins/peptides which modulates
the subsequent cell/scaffold interactions, especially at early times after implantation. In
this work, nanohydroxyapatite and collagen based composite materials (Coll/nanoHA)
were modified with phosphorylated amino acid (O-phospho-L-serine–OPS) to mimic
bone tissue, and induce cell differentiation. The choice for this phosphorylated amino
acid is due to the fact that osteopontin is a serine-rich glycol-phosphoprotein and
has been associated to the early stages of bone formation, and regeneration. Several
concentrations of OPS were added to the Coll/nanoHA scaffold and physico-chemical,
mechanical, and in vitro cell behavior were evaluated. Afterwards, the composite scaffold
with stronger mechanical and best cellular behavior was tested in vivo, with or without
previous in vitro culture of human MSC’s (bone tissue engineering). The OPS signaling
of the biocomposite scaffolds showed similar cellular adhesion and proliferation, but
higher ALP enzyme activity (HBMSC). In vivo bone ectopic formation studies allowed
for a thorough evaluation of the materials for MSC’s osteogenic differentiation. The
OPS-scaffolds results showed that the material could modulated mesenchymal cells
behavior in favor of osteogenic differentiation into late osteoblasts that gave raised
to their ECM with human bone proteins (osteopontin) and calcium deposits. Finally,
OPS-modified scaffolds enhanced cell survival, engraftment, migration, and spatial
distribution within the 3D matrix that could be used as a cell-loaded scaffold for tissue
engineering applications and accelerate bone regeneration processes.
Keywords: biomaterials, cryogel scaffold, collagen, nanohydroxyapatite, phosphoserine modification, guided
bone tissue regeneration
INTRODUCTION
Bone is a mineralized connective tissue constituted by cells and a mineralized extracellular
matrix (ECM) within which the majority of cells are contained (Jayakumar and Di Silvio, 2010).
Mineralized ECM is composed of around 60% mineral, 30% organic matrix, 7% water, and <3%
lipids (Clarke, 2008; Jayakumar and Di Silvio, 2010). The mineral content of bone is mostly
hydroxyapatite, and the organic portion is mainly made of collagen, non-collagenous proteins,
Salgado et al. Biomimetic Scaffold for Bone Regeneration
Graphical Abstract | This article represents a biomimetic Collagen/nanohydroxyapatite scaffolds with phosphoserine (OPS) that affect the in vitro and in vivo cell
response. Together, our findings support the bone tissue engineering potential of the biocomposite scaffold modified with phosphoserine and the regenerative effect
after the biomaterial implantation. Upon this scaffolds implantation, high tissue proliferation rate was observed, and fulfilling all the 3D material structure. Also, with the
human MSC’s, phosphoserine signaling promoted more intense calcium deposition, provide characteristics similar to those of normal bone tissue, favoring its
application in bone tissue engineering.
and proteoglycans (Clarke, 2008). Major bone defects are
associated to trauma, osteonecrosis, tumor removal or
congenital disorders, and the gold standard surgical treatment for
reconstructing bone defects remains the use of bone autografts,
but they are associated to high morbidity due to the need of
obtaining considerable amounts of bone from donor-site and the
area would be left for self-healing (Fernandez de Grado et al.,
2018). However, commercially available products are unable
to reproduce the complex bone structure (i.e., do not mimic
the physical and biological properties of bone tissue), resulting
in undesirable effects such as foreign body response, lack of
regenerative capacity, degradation, and failure in long-term
applications (Wang and Yeung, 2017). When designing novel
regenerative solutions for bone regeneration application, it is
essential to take into consideration defect-specific factors such
as adequate mechanical strength, light weight and flexibility,
a highly porous structure of a scaffold structure (Prasadh
and Wong, 2018). The high swelling ratio and porosity,
adequate mechanical, and biological properties of the scaffolds
was supported by the association of bovine type I collagen
(Coll) to synthetic nanoparticles of hydroxyapatite (nanoHA)
(Rodrigues et al., 2013; Coelho et al., 2015; Salgado et al., 2016).
This composite material has shown increased results in bone
remodeling and a trend toward increased bone implant contact
in the early ingrowth period (Zambonin and Grano, 1995; Wahl
and Czernuszka, 2006; Rodrigues et al., 2013; Coelho et al.,
2015). The scaffold should also afford sufficient void-space and
self-organizing capabilities for cells to expand and promote rapid
host vessel-infiltration upon implantation (Lovett et al., 2009).
To guarantee adequate nutrients and oxygen supply throughout
the scaffold, the cryogel technique (macropore forming
technique), to produce the used scaffolds, should provide a
porous structure with adequate pores size, and interconnectivity
(Henderson et al., 2013).
The association of novel biomaterials and cell-therapies
in tissue engineering strategies could offer new solutions for
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bone regeneration. Mesenchymal stem cells (MSC) hold great
therapeutic potential due to their multi-lineage differentiation
capacity, distinctive immunosuppressive properties and high
expansion potential (Ullah et al., 2015). Transplanted MSC
home to damaged tissues and inflammation sites, constituting
a particularly promising population for regenerative medicine
applications (Law and Chaudhuri, 2013; Wang et al., 2018).
However, in living human tissues, stem cells or progenitor
cells differentiation shall be induced according to biological
clues that in natural tissues may be presented from proteins
or other molecules naturally produced; when dealing with
bone substitutes this molecular signaling must be introduced
in the system (Chen and Liu, 2016). Non-collagenous proteins
normally contain phosphorylated amino acid residues (e.g.,
osteopontin, bone sialoprotein, osteonectin). It is assumed that
these residues are involved in binding protein to hydroxyapatite
(Boskey, 1998). O-Phospho-L-serine (OPS) might be able
to mimic the activities of a non-collagen proteins such as
osteopontin (Hunter et al., 1996). It has been shown that
OPS amino acids have a favorable influence by enhancing the
in vitro viability of osteoblasts in these modified materials
(Reinstorf et al., 2004; Raucci et al., 2014).
In this work, composite scaffolds were developed, based on
collagen/nanohydroxyapatite, and phosphoserine with several
concentrations. The OPS signaling into the scaffolds should affect
the in vitro and in vivo response in terms of human bone cells
adhesion and mesenchymal stem cells osteogenic differentiation.
The overall goal of this work was to develop 3D scaffolds with
enhanced regenerative potential and exceptional integration with





(Coll/nanoHA) Cryogels Modified With
Phosphoserine (OPS)
Biocomposite cryogels (Coll/nanoHA−50/50% w/v) were
produced similarly to previously work (Rodrigues et al.,
2013; Salgado et al., 2016). Briefly, bovine collagen type I
(Sigma-Aldrich, Germany) was homogenized (Ultra Turrax
T25, IKA) at 10,000 rpm in 5mM HCl at a concentration
of 2% (w/v). The solution was mixed with a similar volume
of 2% nanohydroxiapatite solution (nanoXIM.HAp202,
FLUIDINOVA, S.A). Different ratios percentages of O-phospho-
L-serine (OPS–(Sigma-Aldrich, Germany) were added to
final solution (2.5 and 0.5%–OPS5 and OPS1 of total mass,
respectively). All samples were crosslinked with 20mM of
N-hydroxysuccinimide (NHS–Sigma-Aldrich, Germany), and
40mM of 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide
(EDC–Sigma-Aldrich, Germany), and were kept in a freezer at
−18◦C for 24 h to complete the crosslinking. Subsequently, the
scaffolds were washed with distilled water and finally dried in a
freeze-dryer (Labconco, FreeZone 6) at−80◦C for 24 h.
Characterization of Cryogels
Morphological Studies
Morphology of cryogel samples was evaluated using scanning
electron microscopy (SEM, FEI Quanta 400FEG) under
secondary electrons mode. Collagen/nanoHA scaffolds with and
without OPS were attached with AralditeTM to an aluminum
sample holder. Samples were then sputter-coated with palladium-
gold alloy (Bal–Tec—SCD 050). Image analysis through ImageJ
software (Wayne Rasband) was used to determine the scaffolds









Where D and A were respectively, the pore diameter and the
area of the circular projection of the pore in the image. The total
number of pores analyzed for each material was over 200.
Mercury intrusion porosimetry method (Quantachrome
Poremaster model No. 60) was used to evaluate total surface area,
apparent density, and theoretical total porosity of all materials.
The referred equipment allowed the detection of open pores
in the range of 0.004–15.04µm. Each scaffold was entered
by mercury at high pressure, and data were obtained using
Quantachrome Poremaster software.
Physico-Chemical Analysis
Dried samples (2mg) were mixed with 200mg of potassium
bromide (KBr) and compressed into disks. Each disc was
scanned at a resolution of 1 cm−1 over a frequency region
of 400 to 4,000 cm−1 using a Fourier Transform infrared
spectrophotometer (Perkin Elmer, USA) and the characteristic
peaks of IR transmission spectra were recorded (average of
100 scans).
Mechanical Analysis
Dynamic Mechanical Analysis (DMA Tritec 2000, Triton
Technology, UK) was carried-out in wet state (immersion
in phosphate-buffered solution for 1 h), under dynamic
compression solicitation. The scaffolds were subjected to
increasing frequencies ranging from 0.1 to 15Hz at room
temperature. Four samples were tested for each type of scaffold
to obtain the mean values.
In vitro Biological Studies: Cellular
Morphology, Viability, Proliferation and
Differentiation
Cell Culture and Viability Assay
Coll/nanoHA (50/50% w/v) with and without OPS (2.5%)
scaffolds (5 × 4mm) were sterilized by ethylene oxide gas.
Human bone osteosarcoma cell line (MG63, ATCC) was cultured
in α-MEM (alpha modification of Eagle minimum essential
medium, Sigma-Aldrich) supplemented with 10% fetal bovine
serum (FBS, Gibco), 1% penicillin-streptomycin (3× 10−4 mol/L
and 5 × 10−4 mol/L, Gibco) and maintained at 37◦C and 5% of
carbon dioxide (CO2). After cell confluence, cells were seeded by
drop method to Coll/nanoHA scaffolds with and without OPS
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2.5% (1.5× 105 cells/scaffold). The evaluated time points were 7,
14, and 21 days for cellular viability and proliferation evaluation.
Cell vitality was assessed with the non-toxic Alamar Blue dye
[Resazurin, 10% (v/v)] assay. The supernatant was transferred to
a black 96-well plate and fluorescence intensity was measured
using a plate reader (Synergy, BioTek) at 530 and 590 nm for
excitation and emission, respectively. The cellular metabolic
activity results were normalized by the scaffold total DNA content
(ng/mL) measured by the protocol showed at subsection Cellular
proliferation assay. To observe cell differentiation, human bone
marrow stromal cells (HBMSCs, Hospital São João, Portugal)
that were isolated and maintained as described before (Salgado
et al., 2014), and MG63 were cultured for 7, 14, and 21
days, without osteogenic supplements. Only on the control
(2D culture–TCPS), osteogenic supplement (Control DEX) was
added to the medium (0.1mM dexamethasone, 0.1mg.mL−1
ascorbic acid, and 10 mM b-glycerophosphate).
Cellular Morphology
For morphology analysis, the samples were fixed with 4%
paraformaldehyde (Sigma) for 30min and then washed in
PBS (Sigma-Aldrich). Then, the materials were incubated for
10min with 0.1% Triton X100 solution (Sigma-Aldrich), washed
with 1% bovine serum albumin solution (BSA, Sigma-Aldrich),
and the cytoplasm were stained with Alexa Fluor-conjugated
Phalloidin 594 nm (Invitrogen) at 2.5% for 1 h at room
temperature and protected from the light. Nuclei were stained
with DAPI (4′-6-diamidine-2-phenylindole at 0.2%, Invitrogen)
for 5min. For focal adhesion immunostaining, same protocol
were performed for the cell membrane’s permeabilization and
to block non-specific binding. Samples were then incubated
with mouse anti-human vinculin mAb clone hVIN-1 (Sigma)
at a 1:100 dilution for 1 h at room temperature and stained
with Alexa Fluor 594 rabbit anti-mouse IgG, F(ab′)2 fragment
(Molecular Probes) at a 1:400 dilution for 1 h at room
temperature. Samples were subsequently washed and nuclei
were counterstained with 1 µg mL−1 DAPI (Molecular Probes)
for 10min at room temperature. Immunostained cells were
analyzed in three replicates of each scaffold. To evaluate
non-collagenous bone protein, HBMSC cells were culture for
21 days without osteogenic supplements, and the secreted
human osteopontin (OPN) were stained with rabbit anti-
human osteopontin (AB 1870, Merck, 1:500), followed by Alexa
Fluor 488 goat anti-rabbit IgG secondary antibody (Invitrogen
Molecular Probes, 1:1,000) for 1 h each antibody, at room
temperature. To conclude, the images were acquired with a
Leica SP2 AOBS SE camera, with the excitation lasers of
405, 488, and 594 nm.
Cellular Proliferation Assay
DNA content was measured using the Quant-iTTM Picogreen R©
DNA assay (Invitogen, UK) according to the company’s
instructions. After the time-points, scaffolds were incubated with
0.5ml of ultra-pure water at 37◦C for 1 h. Subsequently, they
were put in a freezer at −80◦C for 1 h and then thawed at room
temperature. The supernatant with the lysed cells were collected
and incubaded with Picogreen R© solution for 1 h. Afterwards,
the fluorescence intensity was measured with a microplate
spectrofluorometer (SynergyMx, BioTek) at 480 and 520 nm
excitation and emission, respectively.
Cellular Differentiation Assay
Once the time points were reached, lysed cells supernatant
of the samples were prepared as described above. The ALP
enzyme activity was followed through substrate hydrolysis,
using p-nitrophenol phosphate (Sigma-Aldrich) at pH 10. After
incubation, the reaction was stopped by adding NaOH (1M,
Sigma) and p-nitrophenol was quantified at 405 nm, using a plate
reader (BioTek).
Osteogenic Phenotype Analyses Through mRNA
Expression of Runx-2, Osteopontin (OPN), BMP-2
and Osteocalcin (OC)
Total RNA was extracted from HBMSC with NucleoSpin kit
(Macherey-Nagel), as recommended by the manufacturer.
Subsequently, cDNA synthesis was obtained with the iScriptTM
cDNA Synthesis Kit (BioRad) as recommended by the
manufacturer. After cDNA synthesis reaction, quantitative
real-Time PCR was carried out in mixture containing 1 µL of
cDNA, 10µM of each forward and reverse primers (Runx-2,
BMP-2, Osteopontin–OPN, and Osteocalcin–OC, Table 1) and
10 µL of iTaqTM Universal SYBR R© Green Supermix (BioRad).
qPCR experiments were run using an iQ5 (BioRad) and
analyzed with the iCycler IQ software. The housekeeping gene
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used
as the endogenous assay control. Relative quantification of gene
amplification by qPCR was performed using the cycle threshold
(Ct) values and relative expression levels were calculated using
the 2(−11CT) method. The expression value for each target
gene (Rux-2, BMP-2, OPN, and OC) was normalized to the
GAPDH value at each time point. Results were normalized to
the Coll/nanoHA average results (for day 7 and 14), and are
represented as fold change. Positive control with osteogenic
supplementation (Control—DEX) were also evaluated. For each
PCR, samples were analyzed in duplicate and three independent
experiments were performed.
In vivo Biological Studies: Histology and
Immunohistochemical Analysis
Animal model protocol
HBMSC cells were seeded into Coll/nanoHA scaffolds with and
without phosphoserine (OPS5−2.5%) (5mm diameter and 4mm
of high) and cultured in α-MEM osteogenic complete medium
(0.1mM dexamethasone, 0.1mg.mL−1 ascorbic acid, and 10mM
b-glycerophosphate) for 7 days. Afterwards, blank scaffolds (with
and without OPS5), and scaffolds seeded with cells (1.5 × 105
HBMSCs per scaffold) were subcutaneously transplanted into
the dorsae of four nude female mice, 6 week-old (i3S animal
house, Portugal). The study was performed in accordance with
Animal based studies Ethical Committee and fulfilled all legal
requirements (Approved by the Ethical Animal Commission
of i3S, Portugal). Surgical procedures were performed under
Frontiers in Bioengineering and Biotechnology | www.frontiersin.org 4 September 2019 | Volume 7 | Article 206
Salgado et al. Biomimetic Scaffold for Bone Regeneration
TABLE 1 | Primers for PCR amplification.






standard aseptic conditions. Animals were anesthetized with 3–
5% isoflurane for induction and 1–2% for surgical procedures. A
midline incision through the dorsal skin was performed and two
subcutaneous pockets were created, one on the left side (scaffolds
with HBMSCs) and one on the right (scaffolds without cells) side.
The dorsal wound was then closed with surgical staples. After
recovery, the mice were caged in pairs and allowed to move in
their cages without restriction. They were fed with commercial
mice chow and water for 1, 2, and 4 weeks ad lib. After the
foreseen period of time, the mice were euthanized with carbon
dioxide asphyxiation.
Histology analysis
All samples were explanted and fixed in 10% neutralized buffered
formalin for 24 h and then processed for histology. Fixed samples
were embedded in paraffin and were sectioned longitudinally
with a microtome (5mm of thickness). The sections were
stained with hematoxylin-eosin (H&E), Alizarin red and Von
Kossa (sites of tissue calcium deposition) for light microscopy
examination. Image analysis through ImageJ software (Wayne
Rasband) was used to determine the total tissue ingrowth area
(H&E) and percentage of mineralized tissue (Von Kossa). For the
evaluation of such parameter, over 50 images of each explant were
used (4 replica).
Immunohistochemistry analysis
Immunohistochemistry analysis were performed to follow the
HBMSC presence into the scaffold and secretion of human
osteopontin (OPN) after 4 weeks of implantation. For that
assay, human nuclei, and OPN were probed after antigen
recovery. With this purpose, masked epitopes were exposed
by treatment with citrate buffer (pH 9) for 20min at 97◦C.
Sections were incubated with mouse anti-human nuclei primary
antibody (MAB4383-3 E1.3 Millipore, 1:400, overnight at 4◦C)
and rabbit anti-human osteopontin (AB 1870, Merck, 1:500).
This procedure was followed by 1 h incubation with Alexa
Fluor 594 goat anti-mouse IgG secondary antibody (Invitrogen
Molecular Probes, 1:1,000) and Alexa Fluor 488 goat anti-rabbit
IgG secondary antibody (Invitrogen Molecular Probes, 1:1,000).
All slides were mounted in VectashieldTM with DAPI (Sigma).
Images were obtained using a fluorescence inverted microscope
(Axio Imager Z1, Zeiss). Image analysis through ImageJ software
(Wayne Rasband) was used to determine the percentage of
human cells into the implanted scaffolds (with or not OPS) after
4 weeks (anti-human nuclei antibody). For the evaluation of such
parameter, over 20 images of each explant were used (4 replica).
STATISTICAL ANALYSIS
Data were presented as mean ± standard deviation (n = 3) and
they were analyzed using the one way ANOVA test. Differences






To test the hypothesis that Collagen/nanohydroxyapatite with O-
phospho-L-serine (OPS) can induce cellular differentiation and
bone regeneration, Coll/nanoHA_OPS scaffolds were produced
and characterized in vitro for physico-chemical and mechanical
properties. Also, the material’s biocompatibility and cellular
modulation on in vitro cell culture assays and in a mouse ectopic
bone formation model were tested.
In this work, Coll/nanoHA_OPS scaffolds were produced
using cryogel methodologies, as previously described for other
materials (Lozinsky et al., 2003; Kathuria et al., 2009). To
determine their structure morphology and pores distribution,
all scaffolds were observed using scanning electron microscopy
(SEM). Figures 1A–F shows the SEM images of Coll/nanoHA
scaffolds with and without phosphoserine present in different
concentrations (2.5%–OPS5 and 0.5%–OPS1).
The nanoHA aggregates were homogeneously dispersed
throughout the scaffold pore surface (Figures 1D–F—
black arrows). Overall, all biocomposite scaffolds presented
heterogeneous porous network with macroporosity ranging
from 150 to 400µm and micropores between 10 and 100µm in
diameter. Thus, pores between 10 and 405µm were measured
by the software, with an average pore size of 89.97 ± 75µm for
Coll/nanoHA scaffold, 23.95 ± 65µm for Coll/nanoHA_OPS5
scaffold, and 18.2 ± 60µm for collagen-nanoHA_OPS1 scaffold.
The presence of higher concentration of OPS reduced the
theoretical total porosity (75.77% for Coll/nanoHA and 52.69%
for Coll/nanoHA_OPS5—Table 2), but enhanced the total
surface area (64.05 m²/g for Coll/nanoHA and 70.79 m²/g for
Coll/nanoHA_OPS5—Table 2). Pore size distribution for all the
scaffolds is shown in Figure 1G.
The spectrum of collagen chains (Figure 1H) exhibited
typical proteins bands: amide I (C=O stretching) at 1,658
cm−1, amide II (N-H deformation) at 1,550 cm−1, and amide
III (N-H deformation) at 1,237 cm−1 (Chang and Tanaka,
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FIGURE 1 | Scanning electron micrographs (SEM) of (A,D) Coll/nanoHA scaffold, (B,E) Coll/nanoHA_OPS5 (OPS−2.5%) scaffold, (C,F) Coll/nanoHA_OPS1
(OPS−0.5%) scaffold. Scale bar: 500µm (A–C) and 50µm (D–F). (G) Pore distribution for Coll/nanoHA biocomposite scaffolds with and without OPS. (H) FTIR
spectra of Coll/nanoHA scaffold, Coll/nanoHA_OPS5 scaffold, and Coll/nanoHA_OPS1 scaffold. Storage modulus (I) and Tan delta (J) under dynamic compression
solicitation vs. increasing frequency, ranging from 0.1 to 10Hz. Control–Coll/nanoHA scaffolds.
2002). The hydroxyapatite characteristic peaks were observed
by deconvolution: ν1 P—O symmetric stretch at 873 cm−1; ν3
P—O asymmetric stretch, triple degenerate at 1,031 cm−1; ν4
O—P—O bend, triple degenerate at 564 cm−1. Amide I band
on the Coll/nanoHA with and without OPS appeared at 1,663
cm−1. This band represented the stretching vibration of C=O
and the modification of the band could be probably an indication
of a link of Ca2+ from nanoHA with collagen. This result
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TABLE 2 | Pore size, surface area, and porosity characterization for Coll/nanoHA









Maximum pore diameter (µm) 391 459 346
Minimum pore diameter (µm) 15 2 18
Average pore diameter (µm) 89.97 ± 75 23.95 ± 65 18.2 ± 60
Surface Area (m²/g) 64.05 70.79 23.09
Theoretical porosity (%) 75.77 52.69 45.93
Apparent density (g/cc) 0.54 0.32 0.15
could infer that some nanoHA aggregates had interactions with
the collagen surface through the carbonyl groups present on
the natural structure of the polymer (Wenpo et al., 2015). No
difference between the above referred peaks in the scaffolds with
different concentrations of OPS and the materials without the
modification was observed.
The mechanical properties of the composite scaffolds were
evaluate by DMA. For these cryogels, based on collagen and
nanohydroxyapatite, the storage modulus (E′) is about one order
of magnitude higher than the loss modulus (E′′) indicating an
elastic nature of the biocomposite scaffolds (Rodrigues et al.,
2013). The storagemodulus and tan delta behavior vs. the loading
cycle frequency is reported in Figure 1I. As it may be seen in the
image, at low frequencies, E′ values decreased in the presence of
low and high amounts of OPS when compared to the control
(without phosphoserine). But, at higher frequencies (>10Hz),
the presence of phosphoserine increased the materials’ stiffness.
The loss factor equation tan δ = E′′/E′, indicates the ability of
dispersing the cyclic mechanical energy as heat. The respective
results were plotted in Figure 1J.
In vitro Biological Studies: Cellular
Morphology, Viability, Proliferation and
Differentiation
HBMSC’s showed a tendency of higher cellular metabolic
activity into the scaffolds with higher concentration of OPS
(2.5%) after 7 and 14 days of culture (Figure 2). After 21
days, the cellular metabolic activity decreased to similar values
of the scaffolds with lower OPS concentration and without
the modification (Coll/nanoHA. Although, human osteoblasts
(MG63) and HBMSC’s seeded onto the different cryogels showed
increasing profile in cell proliferation with the time points of
in vitro culture (Figures 3A,C, respectively), following a similar
time-dependent profile. With the MG63 cell line culture, the
effect of the phosphoserine signaling enhanced the proliferation
when compared with the scaffold without OPS, as shown by DNA
concentration after 14 days (Figure 3A). For the HBMSC cell
culture, after 7, and 14 days, there were no statistical differences
between the scaffolds, even with the presence of lower and higher
concentration of phosphoserine (Figure 3C).
In cellular differentiation analysis, increased in ALP enzyme
activity is associated to an early osteoblastic phenotype. Even
FIGURE 2 | HBMSC cellular viability after cultured on Coll/nanoHA (50:50
wt%) with or without OPS (2.5 and 0.5%) for 7, 14, and 21 days. The cellular
metabolic activity results were normalized by total DNA content (ng/mL)
quantified in each time point.
without the addition of osteoinduction supplements (i.e.,
dexamethasone), after 3 weeks, human bone cells (MG63) in
the scaffolds with higher concentration of phosphoserine (OPS5)
expressed ALP activity values similar to those of the positive
control (2D cell culture with osteogenic supplementation–
dexamethasone) as showed in Figure 3B (Control DEX). Also,
in basal conditions, only at day 21, ALP activity was significantly
higher for HBMSCs cultured into Coll/nanoHA_OPS5 scaffolds.
Similar values were also observed with the osteogenic induction
control (dexamethasone). But, lower ALP values were observed
with both cell cultures (MG63 and HBMSC) after 21 days into
Coll/nanoHA_OPS1 scaffolds when compared to simple scaffolds
of Coll/nanoHA (Figure 3D). The scaffolds with lower OPS
percentage showed similar cellular viability, but slightly lower
cellular proliferation and differentiation induction (ALP activity)
after 21 days. These findings seem to indicate that only higher
concentration of OPS (2.5%) immobilized in the scaffold porous
surface was able to stimulate osteogenic differentiation, so only
this modified scaffold was evaluated by qPCR and implanted in
vivo (subcutaneous animal model).
Confocal microscopy images of human bone marrow stromal
cells (HBMSC) seeded on Coll/nanoHA biocomposite scaffolds
with and without phosphoserine (OPS5) were obtained to
observe cells biocompatibility behavior (Figure 4). After 7 days
of culture, it was observed that the cells presenting star
shaped morphology were adherent and well-attached on all the
different samples and for the different time points. Moreover,
it was observed that after 7 days, the highest cell viability
and density were found for the biocomposite cryogels with
phosphoserine, where the cells were well-flattened, showing
many cell membrane extensions (Figures 4A,B,F,G), cell-to-
cell and cell-material surface contact points (Figures 4I,J). At
day 21, both biocomposite scaffolds surfaces and macropores
access walls were almost completely covered by cells that
formed continuous cell layers in some regions. Besides, it
should be observed that cell ingrowth seemed to follow the
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FIGURE 3 | DNA concentration and cells ALP activity after cultured on Coll/nanoHA (50:50 wt%) with or without OPS5 for 7, 14, and 21 days (A, B–MG63 cells;
C,D–HBMSCs). Statistically significant (A) p < 0.05.
FIGURE 4 | Confocal microscopy images of HBMSC cells cultured for 7 and 21 days on Coll/nanoHA (A,B) and Coll/nanoHA_OPS5 (F,G) scaffolds (blue: nuclei, red:
cytoplasm). Human osteopontin immunostaining (green) for HBMSC cell culture after 21 day (C) Coll/nanoHA and (H) Coll/nanoHA_OPS5. Scale: 100µm. SEM
images of 7 days in culture with Coll/nanoHA and Coll/nanoHA_OPS5 (D,I). Immunostaining of focal adhesions (green and blue–DAPI) of HBMSC cells cultured for 1
day on Coll/nanoHA (E) and Coll/nanoHA_OPS5 (J).
irregularities of the materials’ surface, covering both scaffolds
pore walls (Figures 4B,G). These cells also secreted ECM with
bone proteins (osteopontin) after 21 days, showing their capacity
to differentiate in vitro within the scaffolds (Figures 4C,H).
The HBMSC’s cultured into the scaffolds with OPS signaling
showed higher presence of human OPN on the material’s
surface (Figure 4H).
To evaluate the osteoinductive capacity of these materials,
human mesenchymal stromal cells were culture into the
scaffolds with or without phosphoserine in the absence of
dexamethasone (osteogenic inductor). The HBMSC cells gene
expression observed on quantitative real-time PCR after 7
days showed higher levels of osteogenic marks (Runx-2,
OPN, BMP-2, and osteocalcin—Figure 5) in the presence
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FIGURE 5 | qPCR of HBMSC expression after cultured on Coll/nanoHA (50:50 wt%) with OPS5 for 7 and 14 days. It was used the 11Ct method with GAPDH gene
expression as an endogenous reference.
of OPS. Therefore, after 14 days, high gene expression of
bone tissue differentiation (OC, OPN, and Runx-2) could be
observed only for the cells cultured on Coll/nanoHA_OPS5
and the positive control with osteoinduction supplements
(dexamethasone–DEX).
In vivo Biological Studies: Histology
Morphometry and Immunohistochemical
Analysis
Increased tissue ingrowth was observed for the subcutaneous
implants without cell-loaded in vitro culture for modified
biocomposite materials (Coll/nanoHA_OPS5) similar to the in
vitro analysis (Figures 6A, 7A). Scaffolds with HBMSC’s culture
showed higher connective tissue ingrowth when compared to
the empty implanted materials (Figures 6B–D, 7B–D). The
total connective tissue ingrowth area was calculated within
the artificial 3D scaffolds implanted after 7, 14, and 28
days (Figure 8). The results show that the materials modified
with phosphoserine induced the continuous growth of the
surrounding tissue inside the porous scaffold, while without the
OPS, the total tissue area was not statistically different between
2 and 4 weeks after surgery (Figure 8). In the same in vivo
subcutaneous model, it was possible to observe the presence
of giant cells and inflammatory cells such as macrophages
surrounding the apatite particles. Comparable results were also
observed by Baskin et al. (2012).
Similarly, the materials with and without OPS signaling,
after 28 days, showed a visible calcium deposition on the
subcutaneous matrix only on the implants loaded with HBMSC’s
(Figures 6E,F, 7E,F). Nanohydroxyapatite particles and tissue
calcium deposition could be observed with Von Kossa staining
and Alizarin red (dark brown and red dots–Figures 6, 7E,F,
respectively). These calcium crystals staining images showed
that more intense MSC’s osteogenic differentiation occurred
when OPS modified scaffolds were implanted subcutaneously
without the addition of osteogenic synthetic factor such as
dexamethasone (Yoshikawa et al., 1996). More mineralized tissue
formation was evident in the periphery of the scaffold, which
could be directly related to the in vitro seeded HBMSCs and
the material’s incubation for 7 days. These histological results
were confirmed by the semi-quantitative analysis of the implant
slices (Figure 8). The total area of these calcium precipitates
and the relative percentage of area were calculated, and the
scaffold with phosphoserine showed almost 5 times and 2 times
higher, respectively, than the samples without the OPS signaling.
Without the cells, there was no statistical difference between the
different materials (Figure 8 and Table 3).
After immunostaining the human cells in the animal
implants, it could be observed that in all the pre-cultured
scaffolds implanted for 28 days, higher amount of human
MSCs were still present inside the materials. Analyzing the
tissue inside the scaffolds and surrounding it, it was possible
to observe the human MSC’s migrating toward the mouse
tissue (Figures 9A,B,D,E). Thus, the number of HBMSC cells
number inside the biocomposites with phosphoserine after 28
days were considerably higher into a mouse tissue (Figure 9G)
but not statistically different when compared to the control
material. The human proteins secreted by the HBMSC were
evaluated by the detection of human ostepontin (OPN) inside
the scaffold tissue. The presence of the protein is more
evident on the periphery of the OPS- modified scaffolds,
in accordance with the higher number of cells in this
area (Figures 9C,F).
DISCUSSION
The preservation of adequate structural integrity of the scaffold
is critical in tissue engineering and regenerative applications;
besides, cell and tissue growth and remodeling are important
to reach stable biomechanical conditions at the defect site.
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FIGURE 6 | Tissue ingrowth within a Coll/nanoHA after 14 days (A), scaffold with HBMSC culture implanted after (B) 14 days (100µm), (C,D) 28 days (50µm). (E,F)
Von Kossa and Alizarin red. Black arrows—Calcium crystals. BM—Biomaterial; GC—Giant cells; NV—new blood vessels.
Furthermore, in the case of low rate tissue regeneration process
such as bone, the material must provide enough transient
mechanical support to withstand in vivo stresses and loading
(Malafaya et al., 2008). Consequently, mechanical properties
of the materials before implantation are important elements
for their subsequent long-term success or failure (Kelly and
Prendergast, 2006). HA nanoparticles powder, composed by
aggregates of nanophased crystals with size around 100 nm and
a surface area over 120 m2/g was obtained to enhance the
mechanical properties of the collagen/nanoHA biocomposite
scaffolds (Coelho et al., 2015). These particles aggregates
morphology has been previously studied (Laranjeira et al.,
2010) and a wide range of diameter sizes of spherical nanoHA
aggregates were observed. Detailed information about the
material composition could be found in a US patent (US
2017/0042936A1 Feb. 16, 2017). These particles adhesion to the
collagen fibers was very important because particles detachment
could cause significant problems, such as released particles
could migrate to the surrounding tissues and induce a chronic
inflammatory response in the host organs and tissues, or it
could never be released or rapidly dissolved and would remain
within the bone defect (Sena et al., 2009). In this work the
composite scaffolds were produced by cryogelation method.
As described for cryogelation (Lozinsky et al., 2003; Kathuria
et al., 2009), the formation of water crystals (solvent) during
freezing process led collagen and EDC/NHS to stay in a liquid
phase forming stable chemical bonds (crosslink). After thawing,
pores with heterogeneous size and geometry were presented
in the natural polymer. These scaffold production technique
also showed a highly interconnective porous structure (three-
dimensionally). Highly interconnective structure was chosen
to homogenize the cell distribution within the material, and
also to enhance the nutrients and metabolites diffusion inside
the scaffold. Overall, Coll/nanoHA scaffolds structure presented
heterogenous porous network with macro-porosity typically
above 200µm in diameter, and interconnecting micropores
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FIGURE 7 | Tissue ingrowth within a Coll/nanoHA_OPS5 after 14 days (A), scaffold with HBMSC culture implanted after (B) 14 days (100µm), (C,D) 28 days
(50µm). (E,F) Von Kossa and Alizarin red. Black arrows—Calcium crystals. BM—Biomaterial; GC—Giant cells; NV—new blood vessels.
FIGURE 8 | 3D Coll/nanoHA scaffolds with and without OPS implants after 7, 14, and 28 days (percentage of the total section area—µm2 ). Statistically significant
(A,B) p < 0.05.
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(about 10µm). It has been published that an ideal porous
biomaterial should exhibit both micro and macro-porosity
(Rücker et al., 2008; Singh et al., 2009; Wei et al., 2010). Pores
size below 10µm could be essential to transfer of oxygen,
nutrients, and metabolites and also for cell-ECM interactions
(cell adherence), and pores over 100µm in diameter could favor
in vivo tissue ingrowth into the scaffolds (Fierz et al., 2008).
DMA analysis of Coll/nanoHA_OPS scaffolds were performed
in wet state, because more accurate data of the mechanical
properties could be gained from the natural polymer and also to
better mimic the physiological conditions in which the materials
should potentially be used. In the analysis, both storage and
loss modulus (E′ and E′′) were measured between 0.1 and
TABLE 3 | After 28 days of scaffolds subcutaneous implantation, connective
tissue calcification (calcium tissue deposition) reached the total area calculated by
ImageJ software in µm2.
Cells Materials Total area (µm2) % of area
– Coll/nanoHA_OPS5 321.7 ± 34.5 0.34 ± 0.11
– Coll/nanoHA 163.5 ± 62.6 0.18 ± 0.09
HBMSC Coll/nanoHA_OPS5 556.1± 137.3 0.59 ± 0.15
HBMSC Coll/nanoHA 108 ± 68.8 0.14 ± 0.042
20Hz of frequency, which are typical low and high solicitation
described in physiological situations in load-bearing applications
(Roach et al., 2007; Chen et al., 2012). Regarding the dynamic
mechanical evaluation, composite scaffolds with phosphoserine
showed extraordinary tension dissipation ability, related to
hindering properties, especially at low and high frequencies,
which can be a very useful feature in view of in vivo implantation
(Zadpoor, 2017). Significant differences on the tan delta results
were observed between the cryogels with and without OPS.
Therefore, it could be concluded that the material became more
viscous (permanent deformation) and less elastic in the presence
of phosphoserine modification.
When the cells were into the biomaterials structure, they
should have some morphological changes in order to stabilize
the cell-surface interface. In the occurrence of cell adhesion to
the materials’ surface, the most important results relates to a
more organized cellular network, cell membrane elongation with
filopodia extensions (Khalili and Ahmad, 2015). Consequently,
not only the chemical surface, but also topology is an important
aspect that interferes on the cellular behavior (Beringer et al.,
2015). After cellular contact with the scaffolds signaling
OPS (MG63 and HBMSC), there were no differences in
their morphology, adhesion capacity and proliferation, when
compared to the control scaffold (Coll/nanoHA). Human bone
FIGURE 9 | Connective tissue ingrowth within Coll/nanoHA (A–C) and with OPS5 (D–F) with HBMSC culture implanted for 28 days. Mouse cells nuclei in blue, HuNu
in pink (human nuclear staining), and OPN in green. (G) Quantitative image analysis of human MSC’s presence (percentage) into the scaffolds with and without OPS
signaling after 4 weeks of implantation.
Frontiers in Bioengineering and Biotechnology | www.frontiersin.org 12 September 2019 | Volume 7 | Article 206
Salgado et al. Biomimetic Scaffold for Bone Regeneration
marrow cells had a progressive differentiation pathway that
start with pre-osteoblasts and later became osteoblasts. Once
the final differentiation state was reached, cells could secrete
ECM proteins for the matrix mineralization (Wang et al., 2016).
Therefore, the HBMSC’s revealed a tendency to a decrease in
the cellular metabolic activity (Figure 2), but these results are
similar to findings published in the literature. Some authors
stated that with osteoinduction, the human MSC’s entered in
the stage of osteoblastic differentiation, showing lower level
of cell proliferation and metabolic activity. The researchers
presented that all the materials that exhibited decreasing levels
of proliferation also showed increasing levels of differentiation,
increased ALP activity and osteocalcin (OC) gene expression
levels (Schwartz et al., 1999; Carvalho et al., 2016). Indeed, it
was observed an increasing of cellular proliferation (Figure 3C),
along the studied period, this behavior was a positive result that
should end-up by leading to a normal tissue growth for the
proposed clinical application.
The ability of human MSCs to produce different lineages is
now a well-known concept and their osteogenic differentiation
potential has become one of the most researched topics in bone
regeneration (Abbah et al., 2008). Encouraging results have been
obtained when using osteoblasts differentiated from MSCs in
bone regenerative processes (Healy and Guldberg, 2007; Moioli
et al., 2007). Along these findings and targeting at developing
a bone tissue engineering approach, the differentiation of
immobilized HBMSCs toward the osteogenic lineage was
explored by analyzing several cell differentiation markers. First,
the activity of ALP enzyme, an early osteoblastic marker “infer”
the stage of cell differentiation. The activity of this enzyme
increases during synthesis of the extracellular matrix, which
matches to the beginning of cell differentiation (Stein et al.,
1990). This in vitro test could disclose the osteoconductive effect
for phosphoserine and its essential role on the mesenchymal
stromal cells differentiation (Supplementary Material), which
could be observed in the enhancement of the ALP enzyme
activity on early times of cells cultures only for the OPS
modified scaffolds. The osteoconductive effect were also
observe in CaP cements modified with phosphoserine that
clearly enhanced cell line differentiation showed by alkaline
phosphatase activity and expression of typical osteogenicmarkers
(Raucci et al., 2014).
Many transcription factors are responsible for the
commitment of multipotent mesenchymal cells into the
osteoblast cell lineage. A valuable factor is Runx-2, that is able
to up-regulate the expression of the main bone ECM protein
genes, such as osteopontin and osteocalcin, leading to a higher
number of immature osteoblasts from multipotent stem cells.
The advanced development of the osteoblastc phenotype from
a non-differentiated cell to an established osteoblastic cell is
considered by a sequence of specific genes expression that
remain over three periods of osteoblast phenotype development:
proliferation, in a sequence of maturation and ECM synthesis,
and as a final point, the mineral deposition onto the matrix
(Neve et al., 2011). Many works propose that osteocalcin (OC)
is involved in the mineral deposition regulation and that it
acts as a signal for osteoblast activation and differentiation
(Chenu et al., 1994), confirming that OC is a biomarker for
mature osteoblasts (Lian et al., 2001). Concerning the cells gene
expression and osteogenic markers, the results indicated that
the osteoblast gene markers could be readily regulated in an
ECM-mediated way. Cell contact with ECM proteins is very
significant on regulating the osteogenic differentiation of human
MSCs (Sun et al., 2018). Our data strongly suggested through
the real-time PCR results, that the presence of phosphoserine
enhanced the expression of osteogenic gene markers, as early
as 7 days in culture even without any osteogenic supplement
(dexamethasone). Those results showed similar gene expression
when compared to a positive control of a 2D cell culture
with osteogenic induction culture medium (dexamethasone).
These findings also corroborate to the in vitro results that
showed bone proteins presence (OPN) in the HBMSC’s ECM
after 21 days. Therefore, the scaffolds’ osteoconduction effect
on the HBMSC’s were higher observed with the presence of
OPS molecules.
The mouse subcutaneous model is commonly accepted as
the ideal initial model for investigating the in vivo behavior
of bone substitutes (Yokoyama et al., 2005; Tommila et al.,
2008). For this study, 1, 2, and 4 week duration period were
selected because the intent was to assess thematerial performance
during short-term inflammation (1 and 2 weeks), and also
evaluate the response after 4 weeks, to observe when could
occur a significant in vivo degradation of the material (Tommila
et al., 2008). After implanted Coll/nanoHA_OPS scaffolds, the
histological evaluation was performed at day 7 revealed that
the scaffold structure was still present. The maintenance of the
3D structure should be related to the chemical bonding of the
collagen fibrils allowed by the crosslinking step (EDC/NHS).
After the in vivo implantation, we could observe porous scaffold
architecture similar to a non-implanted material. Besides, the
histological findings indicate that Coll/nanoHA supported tissue
ingrowth and new micro-vascularization. Importantly, in the
context of tissue healing, granulation tissue replaces hematoma
during the early stages of tissue repair. Previous reports showed
that Coll/nanoHA cell-binding domains could promote in vivo
migration and proliferation (Rodrigues et al., 2013; Salgado et al.,
2016) of animal fibroblasts, an important cell population involved
in granulation tissue formation and wound healing (Micallef
et al., 2012). It was observed that the presence of phosphoserine
not only enhanced the percentage of the total tissue ingrowth
along the time-points, being statistically different from the
material without the OPS after 14 and 28 days (Figure 8). Four
weeks after implantation, newly ECM with human OPN and
calcium deposition was observed, only for materials cultured
with the HBMSCs seeded and cultured in vitro for 7 days
(Figures 6F, 7F, 9E). In some animals, the presence of residual
highly vascularized soft tissue inside the implant could still be
observed. The bone-like tissue formation was only observed in
the periphery of the scaffold, which may be related with the
fact that higher number of HBMSCs adhered and proliferated
on the periphery after 7 days of in vitro culture. Also, calcium
tissue deposition, as an early stage of ECM mineralization
(ectopic bone tissue formation) occurred from the periphery
to the central region of the scaffolds. Even in implants into
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bone critical defects (4mm), 4 weeks should not be enough
time to observe mature bone tissue. Usually, in ectopic bone
formation model, the bone tissue growth should be observed
only after 12 weeks (Scotti et al., 2013). In a previous work,
no evidence of the material’s bovine collagen was observed in a
study after 8 weeks post-implantation, suggesting that scaffold
biodegradation by endogenous collagenase had taken place,
without impairing tissue regeneration (Salgado et al., 2016).
These findings suggest an enhancement of humanMSC’s activity,
as would be expected with the molecular stimuli present on
the materials’ surface (OPS). Since the scaffolds composition
and cellular organization of the pre-formed cell culture undergo
dynamic changes after implantation, it was important to evaluate
the materials tissue engineering potential application. Therefore,
to track the implanted HBMSCs, a specific human nucleic
marker was used (HuNu, nuclear pink-stain) (Figure 9). Human
cell culture presence in the scaffold and migration capacity
was observed from the early times of implantation (7 days)
to the latest ones (28 days). These cells were viable as they
secreted human OPN (natural bone ECM), these findings are in
accordance with the number of HBMSC’s as the protein presence
is more evident in the materials with OPS modification. OPS
signaling toward the cells cultured into the scaffolds probably
were responsible for the bone differentiation of the HBMSC in
the ectopic bone formation on the mice model and also allowed
the transplanted human cells not only to survive, but to grow,
migrate and differentiate into the desired tissue.
Altogether, our findings support the bone regenerative
potential of the biocomposite scaffold modified with
phosphoserine and potentially regulate the cellular bone
differentiation after the scaffold implantation. Upon the
explant evaluation, high cellular proliferation of subcutaneous
tissue was observed, with more organized conjunctive tissue
and full-filling all the 3D material structure. Also, with the
human MSC’s, phosphoserine signaling promoted higher
tissue mineralization in comparison to the control group (only
collagen and nanohydroxyapatite). In the future, new studies are
required to acquire a comprehensive understanding of how OPS
presence supports bone healing and its effect on cell migration
and differentiation.
CONCLUSIONS
The main advantage of scaffold modification with O-phospho-L-
serine by cryogel method is the osteoinductive signaling, without
biocompatible manufacturing. Moreover, the hydroxyapatite
nanoparticles have significant influence on the materials
behavior, but slight modifications could be observed on the
materials mechanical properties with the OPS presence. The
in vitro cell behavior analysis with MG63 and HBMSC cells
exhibited a progressively strong cell viability and proliferation
along the period of observation. After these in vitro results, the
ideal composition was identified as being 2.5% of phosphoserine
(Coll/nanoHA_OPS5) by detecting similar values either for
ALP enzyme activity or for several differentiation gene
markers through qPCR analysis (OC, Runx-2 OPN) of the
positive control (osteoinduction supplement). Ectopic bone
formation animal model results of materials loaded with
HBMSCs showed increased calcium tissue deposition in the
presence of phosphoserine. Also, lower implantation periods
showed a reduced inflammatory response with new micro-
vascularization formation inside and around the implant. The
data from this work indicate that the biocomposite with
higher content of O-phospho-L-serine had higher capacity
to promote differentiation of human MSC’s, enhance cell
viability and bone tissue ECM production (OPN and presence
of calcium ions) in vivo. The OPS signaling composite
scaffold showed an appropriated design, cell distribution
and behavior that provide characteristics similar to those
of normal bone tissue favoring its application in bone
tissue engineering.
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